Brazil

Brazil's COINFAR, a biotech joint venture between Aché, Biolab Sanus and União Química, has made available BRL3mn (US$1.8mn) to develop compounds derived from the country's biodiversity.... 2008-03-18

Brazil's COINFAR, a biotech joint venture between Aché, Biolab Sanus and União Química, has made available BRL3mn (US$1.8mn) to develop compounds derived from the country's biodiversity.... 2008-03-18

Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical... 2008-03-14

Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical... 2008-03-14

Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical... 2008-03-14

Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical... 2008-03-14

India's Strides Arcolab and South Africa's Aspen Pharmacare have completed their tie-up, which gives Aspen a 50% stake in Strides' Latin American operations. Aspen injected US$152.5mn... 2008-03-07

India's Strides Arcolab and South Africa's Aspen Pharmacare have completed their tie-up, which gives Aspen a 50% stake in Strides' Latin American operations. Aspen injected US$152.5mn... 2008-03-07

On February 21, the world's largest generics company, Israel's Teva Pharmaceutical Industries held its investor day in New York - an event monitored by BMI's pharma team. Teva outlined... 2008-02-22

Authorities have agreed that two key Cuban-developed pharmaceuticals that were previously exported to Brazil can now be manufactured by Brazil's state drugmaker, the Oswaldo Cruz... 2008-02-20